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Abstract
Klebsiella species infrequently cause acute community acquired pneumonia (CAP). The chronic form of the disease caused by 
K. pneumoniae (Friedlander’s bacillus) was occasionally seen in the pre-antibiotic era. K. oxytoca is a singularly uncommon cause of 
CAP. The chronic form of the disease caused by K. oxytoca has been documented only once before. A 50-year-old immunocompetent 
male smoker presented with haemoptysis for 12 months. Imaging demonstrated a cavitary lesion in the right upper lobe with emphy-
sematous changes. Sputum stains and cultures for Mycobacterium tuberculosis were negative. However, three sputum samples for 
aerobic culture as well as bronchial aspirate cultured pure growth of K. oxytoca. A diagnosis of chronic pneumonia due to K. oxytoca 
was established and with appropriate therapy, the patient was largely asymptomatic. The remarkable clinical and radiological simila-
rity to pulmonary tuberculosis can result in patients with chronic Klebsiella pneumonia erroneously receiving anti-tuberculous therapy.
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Introduction
Klebsiella, an aerobic gram-negative bacillus, 
is a rare but well established cause of community 
acquired pneumonia (CAP), especially in the pre- 
-antibiotic era [1]. This organism continues to be 
an infrequent source of CAP accounting for 1−5% 
of the patients [2−4]. However, two studies have 
documented Klebsiella as a causative organism 
of CAP in as high as 12 and 22% of the patients 
respectively [5, 6]. Although, an uncommon cause 
of CAP, hospital acquired pneumonia caused by 
Klebsiella is fairly frequent and can be life thre-
atening [7, 8]. 
CAP due to K. pneumoniae usually has an 
acute presentation resembling that of pneumococ-
cal lobar pneumonia, occurring almost exclusi-
vely in debilitated subjects [5]. Rarely, pneumonia 
caused by Klebsiella species can manifest as 
a chronic disease, which can last for weeks or 
months. This singularly uncommon form of the 
disease may be seen in elderly subjects and the 
presentation is strikingly similar to that of pulmo-
nary tuberculosis [1, 9−11]. In high tuberculous 
prevalent areas, this unusual clinical entity can 
often be misdiagnosed and treated for tuberculo-
sis while lung damage continues to occur [11]. 
Other important conditions that can simulate 
pulmonary tuberculosis radiologically include 
non-tuberculous mycobacterial infections, other 
bacterial pneumonias especially pulmonary no-
cardiosis, fungal infections, allergic bronchopul-
monary aspergillosis and lung malignancies [12]. 
Although K. pneumoniae (Friedlander’s bacillus) 
is the most commonly cultured organism, three 
other species viz. K. oxytoca, K. rhinoscleromatis 
and K. ozaenae can also be responsible infrequ-
ently [13]. K. oxytoca has rarely been implicated 
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Figure 2. HRCT of the thorax demonstrated thick walled cavity in 
apical segment of right upper lobe surrounded by fibrosis and cen-
trilobular nodules while emphysematous bullous area was seen in 
left upper lobe
Figure 1. Chest apicogram done on presentation showed the presence 
of a small cavity in right upper zone with increased lung markings as 
compared to the left upper zone
as a cause of CAP. The reports available in the 
literature suggest that CAP due to this organism 
has an acute manifestation. This was highlighted 
by a study from Switzerland which reported 
12 (12.4%) patients with CAP requiring hospita-
lisation due to Klebsiella species which included 
two caused by K. oxytoca [5]. The chronic form 
of the disease caused by K. oxytoca has been do-
cumented only once previously in an 82-year-old 
female from Canada who presented with a non- 
-resolving pneumonia of 9 months duration [14]. 
The paucity of the literature on the subject 
prompted us to report a middle-aged man with 
a 30-pack-year history of smoking who presented 
with chronic necrotising pneumonia of 12 months 
duration caused by K. oxytoca.
Case report
A 50-year-old male, non-diabetic, HIV-nega-
tive, a farmer by occupation, was referred to our 
Institute for evaluation of haemoptysis of 12 mon-
ths duration. Haemoptysis was intermittent with 
10 to 12 episodes over the past year. Blood was 
often mixed with sputum but recently he had 
experienced two episodes where he had expecto-
rated about 500 mL of frank blood, which promp-
ted the referral. For the preceding two months this 
was associated with cough and expectoration of 
approximately four to five teaspoonful of non-foul 
smelling muco-purulent sputum. He had smoked 
30 pack-years before quitting one year ago with 
the first episode of haemoptysis. He had received 
several short courses of oral antibiotics for this 
complaint without relief. However, he had not 
received anti-tuberculous therapy. On presen-
tation, general physical and respiratory system 
examinations were unremarkable.
Complete blood counts, ECG, urine analyses 
and renal as well as hepatic function test results 
were within normal limits. Chest apicogram done 
on presentation showed the presence of a small ca-
vity in right upper zone with increased lung mar-
kings as compared to the left upper zone (Fig. 1). 
A high resolution computed tomography (HRCT) 
of the thorax demonstrated thick walled cavity in 
apical segment of right upper lobe surrounded by 
fibrosis and centrilobular nodules while emphy-
sematous bullous area was seen in left upper lobe 
(Fig. 2). Paraseptal emphysema was also visible 
bilaterally along with centrilobular emphysema 
in the left lung. Small nodular lesions were also 
visible in left lower lobe. However, spirometry 
with reversibility was within normal limits with 
post-bronchodilator FEV1/FVC ratio of 0.77.
Several stains for acid-fast bacilli (AFB) 
done prior to presentation were negative. Three 
sputum smears for AFB and cultures for Myco-
bacterium tuberculosis done at presentation were 
also negative. K. oxytoca was isolated as a pure 
growth in sputum culture performed for aerobic 
bacteria other than M. tuberculosis. The organism 
was cultured in the initial sample and the sub-
sequent two samples also and was sensitive to 
almost all common antibiotics. Fiberoptic bron-
choscopy visualised a normal bronchial mucosa. 
Cytological examination of the bronchial aspi-
rate smear showed benign columnar epithelial 
cells, moderate infiltration of lymphocytes and 
few macrophages with no malignant cells. Ae-
robic culture of the aspirate also yielded pure 
growth of K. oxytoca. Stains and cultures for 
M. tuberculosis or other aerobic organisms con-
tinued to be negative.
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A diagnosis of chronic pneumonia caused by 
K. oxytoca was made. Although the spirometry was 
within normal limits, the patient had a 30-pac-
k-year history of smoking and the CT picture was 
suggestive of emphysema. The patient had never 
experienced any symptoms suggestive of exacer-
bation of chronic obstructive pulmonary disease 
(COPD) nor had he ever received inhaled/oral 
corticosteroids or any other therapy. Based on 
the culture sensitivity report, the patient received 
antimicrobial therapy with oral amoxicillin/clavu-
lanic acid (500 + 125 mg 8 hourly) along with 
intravenous gentamicin (160 mg 12 hourly) for 
a fortnight. With this, the patient experienced 
marked symptomatic improvement and within 
2 weeks, haemoptysis was largely abolished. The 
patient was relatively symptom-free and after 
3 months he was lost to follow-up.
Discussion
Pneumonia due to Klebsiella generally occu-
rs in elderly people with risk factors including 
alcoholism, diabetes mellitus, smoking, co-mor-
bidities such as COPD and other debilitating 
illnesses [6, 13]. Of the 2,776 patients hospita-
lised for CAP in 1991 in two counties in Ohio, 
Klebsiella species were implicated in 29 (1%) 
[3]. The retrospective study from Switzerland 
[5] in 293 hospitalised patients with bacterial 
pneumonia, specific bacteriological aetiologies 
were found in 97 (33.1%). Twelve (12.4%) of 
these patients were due to Klebsiella species [5]. 
A prospective study in 70 patients with CAP 
from India reported aetiological confirmation in 
53 (75.6%), 12 (22.6%) of whom were caused by 
K. pneumoniae [6]. 
K. pneumoniae is usually the causative spe-
cies but K. oxytoca as a potentially significant 
respiratory pathogen was first recognised in a re-
trospective study in 1983. This study found that 
of the 4,800 patients with respiratory complaints, 
110 sputum samples and one blood culture were 
positive for Klebsiella species. Of these, K. oxytoca 
was isolated in 11 samples from 11 patients inc-
luding the one from blood culture. Four of these 
11 patients had lobar pneumonia while one had 
bronchopneumonia, five had acute exacerbations 
of chronic bronchitis and one had an acute respira-
tory tract infection superimposed on cryptogenic 
fibrosing alveolitis. The authors advocated that 
treatment was indicated whenever this organism 
was isolated from the clinical specimens [15].
In another prospective study [16] of 15 patients 
with bacteremically proven Klebsiella pneumonia, 
right upper lobe involvement was documented in 
11 cases. The authors observed that immunosu-
pression was a significant risk factor for Klebsiella 
pneumonia and infections were mostly hospital 
acquired. Of the 15 patients, K. oxytoca was iso-
lated in five, four of whom had bilateral disease. 
The authors stated that K. oxytoca was seen more 
often in patients with bilateral infiltrates while K. 
pneumoniae was more common in patients with 
unilateral infiltrates [16]. Our patient too had right 
upper lobe necrotising pneumonia with infiltrates 
in the left lung. K. oxytoca has also been impli-
cated as an offending agent for hypersensitivity 
pneumonitis [17]. 
The chronic form of the disease caused by 
Klebsiella species is rarely encountered. In the 
pre-antibiotic era, Solomon [1] reviewed 17 pa-
tients with chronic Friedlander pneumonia and do-
cumented that it occurred predominantly in males 
in the later decades and especially those affected 
by alcoholism. Upper lobe lesions were seen in 
14 (82%) patients and the involvement of multiple 
lobes occurred in 5 (30%). Lung abscesses were 
documented in majority of these patients. Both 
lungs were involved in only two patients. The 
author further stated that frequent occurrence of 
blood streaking and mucopurulent sputum along 
with the cavities in upper lobes on chest X-ray 
can lead to strong suspicion and even treatment 
for pulmonary tuberculosis in these patients [1].
A study published from Japan [18] repor-
ted four patients with Klebsiella (Friedlander’s) 
pneumonia of whom, one had a chronic pre-
sentation with typical cavitary lung abscesses 
in the right lung [18]. Chronic presentation of 
pneumonia due to K. pneumoniae has also been 
reported from India in an immunocompetent 
elderly male. He was a reformed smoker who, 
prior to presentation, had received anti-tuber-
culous therapy with no relief due to marked 
clinical and radiological resemblance to that of 
pulmonary tuberculosis. Subsequently, a dia-
gnosis of chronic Klebsiella pneumonia was 
established when initial sputum samples cul-
tured K. pneumoniae. The patient had a marked 
symptomatic improvement with appropriate 
antibiotics and was largely symptom free. 
A chest X-ray done after eight months showed 
considerable clearing of the lesion with some 
remaining fibrosis [11]. Imaging in our current 
patient too had a marked resemblance to that of 
pulmonary tuberculosis as there was cavitation 
in the right upper lobe. 
Non-resolving pneumonia of 9 months dura-
tion caused by K. oxytoca has been documented 
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only once before from Canada in an 82-year-old 
previously healthy woman with a 30 pack-year 
history of smoking. Radiologically, the patient 
had an extensive consolidation of the left lower 
lobe with volume loss, which was confirmed on 
HRCT along with emphysematous changes. The 
diagnosis was established with the culture of the 
organism from bronchoalveolar lavage [14]. In our 
patient too, non-resolving pneumonia along with 
a history of smoking and emphysematous changes 
were present. K. oxytoca was cultured as a pure 
growth from both sputum samples as well as the 
bronchial aspirate. 
The chronic presentation of pneumonia caused 
by K. pneumoniae is an uncommon clinical entity 
while that due to K. oxytoca is a distinct rarity as it 
has been documented only once before. Physicians, 
especially in high tuberculous prevalent areas, sho-
uld be aware that the chronic form of the disease 
due to Klebsiella species can have a presentation 
akin to that of pulmonary tuberculosis.
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